Big Boost in Drug Discovery: New Use for Stem Cells Identifies a Promising Way to Target ALS

The new screening technique developed by Lee Rubin, a member of HSCI's executive committee and a professor in Harvard's Department of Stem Cell and Regenerative Biology , had predicted that the two drugs that eventually failed in the third and final stage of human testing would do just that.

http://www.sciencedaily.com/releases/2013/04/130418124901.htm